Your browser doesn't support javascript.
loading
Safety and costs of blood transfusion practices in dengue cases in Brazil.
Machado, Alessandra Aparecida Vieira; Negrão, Fábio Juliano; Croda, Júlio; de Medeiros, Elias Silva; Pires, Maria Aparecida Dos Santos.
Afiliação
  • Machado AAV; Health Sciences College, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
  • Negrão FJ; Health Sciences College, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
  • Croda J; Universitary Hospital of Federal University of Grande Dourados, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
  • de Medeiros ES; School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
  • Pires MADS; Oswaldo Cruz Foundation, Campo Grande, Mato Grosso do Sul, Brazil.
PLoS One ; 14(7): e0219287, 2019.
Article em En | MEDLINE | ID: mdl-31283788
ABSTRACT

BACKGROUND:

Dengue is a public health problem, and noncompliance with World Health Organization (WHO) recommendations for blood transfusion components is frequently reported. Moreover, economic impact studies of the WHO recommendations on the use of blood transfusion are scarce.

METHODS:

We compared the cost and hospitalization time in a prospective observational study, by following hospitalised patients and analysing their medical records from 2010 and March 2016 to December 2017. We divided the patients into two groups transfused (with or without WHO criteria for transfusion) and not transfused (with or without WHO criteria for transfusion). Generalised linear modelling was performed to identify the variable that could increase the costs and hospital stay.

RESULTS:

Among 323 patients, 52 were transfused, of whom 52% without criteria (n = 27), and 271 were not transfused, of which 4.4% (n = 12) with criteria. Hospitalisation costs were 41% higher in the transfused group without criteria than in those with criteria (median US$ 674.3 vs US$ 478 p = 0.293). Patients who were not transfused but met the WHO criteria for transfusion (n = 12) had longer mean hospitalisation time than did those who were not transfused (3.8±3.4 days versus 3.6±3.1 days; p = 0.022). The GLM analysis using hospital stay and costs as the dependent variable explained approximately 33.4% (R2 = 0.334) of the hospitalisation time and 79.3% (R2 = 0.793) of costs. Receiving a transfusion increased the hospitalization time by 1.29 days (p = 0.0007; IRR = 1.29), and the costs were 5.1 times higher than those without receiving blood components (IRR = 5.1; p< 0.001; median US$ 504.4 vs US$ 170.7). In contrast, patients who were transfused according to WHO criteria had a reduction in costs of approximately 96% (IRR = 0.044; p<0.001; ß = -3.12) compared to that for those who were not transfused according to WHO criteria (without criteria).

CONCLUSION:

Transfusion without following WHO recommendations increased the time and cost of hospitalisation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transfusão de Sangue / Dengue Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transfusão de Sangue / Dengue Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2019 Tipo de documento: Article